CEPI CEPI is a global partnership working to accelerate the development of vaccines and other biologic countermeasures against epidemic and pandemic threats so they can be accessible to all people in need
About CEPI CEPI is an innovative global partnership between public, private, philanthropic, and civil society organisations launched in Davos in 2017 to accelerate the development of vaccines and other biologic countermeasures against epidemic and pandemic threats so they can be accessible to all people in need
Calls for Proposals - CEPI CEPI’s pandemic plan aims to substantially reduce or even eliminate the future risk of pandemics and epidemics The plan is set around three pillars: prepare for known threats; transform the response to the next novel outbreak; and connect and enhance global collaboration to strengthen global preparedness
Securing the Future - cepi. net CEPI 3 0 – our 2027-2031 strategy – aims to transform the world’s ability to tackle epidemic and pandemic threats Explore CEPI’s 3 0 Investment Case to see how we can #SecureTheFuture together
Progress and results - CEPI CEPI is catalysing the development of vaccines and biologics against epidemic and pandemic threats, working to make them accessible to everyone who needs them and driving progress on the 100 Days Mission Learn more about our progress and results
STRATEGY - static. cepi. net CEPI 3 0 builds on the achievements and lessons of our first decade, translating them into a strategy focused squarely on delivery, resilience and impact
ANNUAL PROGRESS REPORT - static. cepi. net CEPI’s vaccine portfolio made major strides, bringing the prospect of protection against our priority pathogens closer than ever before, while making important contributions to the scientific knowledge and preparedness infrastructure that underpin the 100 Days Mission A CEPI-supported Lassa vaccine became the first to reach Phase 2 trials, with Nipah and Rift Valley fever vaccines on the
Impact in focus - cepi. net CEPI supports more than 150 active R D and manufacturing projects in nearly 50 countries around the world, building critical capabilities for the 100 Days Mission Find out how CEPI is advancing scientific innovations that could transform vaccine development and pandemic preparedness
What we do - CEPI CEPI leverages its unique position within the global health and R D ecosystems to address market failures, building on its proven track record of bringing together public-sector, private-sector, and academic partners to accelerate the development of vaccines against emerging viral threats
Our portfolio - CEPI CEPI funds the development of vaccine candidates against our known priority pathogens and vaccine platforms to enable rapid development of vaccines against Disease X Our interactive portfolio provides information on each of the vaccine candidates that CEPI has invested in as well as our Centralised Lab Network, Preclinical Models and Vaccine Manufacturing Network partners Filter information